Panjon Ltd.
Snapshot View

View in App

Prices View details >>

12.00 0.00

29 March 2023, 04:01:00 PM
Volume: 30,921

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.panjon.in
Market Cap 18.83 Cr.
Enterprise Value(EV) 19.49 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -2.60 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 32.17 Trailing Twelve Months Ending 2022-12
Book Value / Share 8.25 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.47 Calculated using Price: 12.15
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.55 Cr. 15,498,700 Shares
FaceValue 10
Company Profile
No Company Profile found.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-7.69%
1 Month
-16.96%
3 Month
-36.00%
6 Month
-14.83%
1 Year
-32.96%
2 Year
5 Year
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -0.98 -17.68 2.23 0.71 0.74 0.84 -0.19 0.57 -28.17
Return on Capital Employed (%) 0.43 -22.21 0.94 1.75 2.03 2.59 1.84 1.60 -24.99
Return on Assets (%) -0.68 -15.33 2.11 0.68 0.70 0.78 -0.18 0.52 -25.77

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 24 16 16 17 17 17 17 17 13 13
Non Curr. Liab. 2 1 0 0 0 0 1 0 0 0
Curr. Liab. 1 1 0 1 1 1 1 1 1 1
Minority Int.
Equity & Liab. 27 17 17 17 18 18 19 19 14 14
Non Curr. Assets 7 2 2 2 10 9 7 7 5 2
Curr. Assets 19 15 15 15 8 9 11 12 9 12
Misc. Exp. not W/O 2
Total Assets 27 17 17 17 18 18 19 19 14 14

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 19 19 12 14 20 26 26 15 8 6
Other Income 0 0 0 1 0 0 0 0 0 0
Total Income 19 20 13 15 20 26 27 15 9 7
Total Expenditure -19 -23 -12 -14 -20 -26 -26 -14 -12 -10
PBIDT 0 -3 0 0 0 1 1 1 -4 -4
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 1 0 0 0 0 0 0 0
Exceptional Items -2
PAT 0 -3 0 0 0 0 0 0 -4 -4
Adjusted EPS 0 -2 0 0 0 0 0 0 -3 -3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -6 -3 1 0 0 0 0 0 0 2
Cash Fr. Inv. 0 0 5 0 0 0 0 -1 0 0
Cash Fr. Finan. 6 3 -5 0 0 0 0 0 0 -1
Net Change 0 0 0 0 0 0 0 0 0 1
Cash & Cash Eqvt 0 0 1 0 0 0 1 0 0 1

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 52.03 52.03 52.03 52.03 52.03 52.03 52.03 52.03 52.03
Public 47.97 47.97 47.97 47.97 47.97 47.97 47.97 47.97 47.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 27 Mar 2023
Closure of Trading Window
This is to inform that as per the PANJON LIMITED (Company) Code of Conduct for Prevention of Insider Trading for regulating monitoring and reporting of trading by Designated Persons formulated in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in securities of the Company by Designated Persons shall remain closed from Saturday April 01 2023 until 48 hours after the announcement of the Audited financial results of the Company for the quarter and year ended March 31 2023. The Board meeting for approving the Audited financial results for the quarter and year ended March 31 2023 will be held on or before May 30 2023. Accordingly all Designated Persons and their immediate relatives have been advised not to trade in the securities of the Company during the aforesaid period of closure of Trading Window.
Tue, 14 Feb 2023
Revised Un-Audited Standalone Financial Results Of The Company Along With The Limited Review Report For Nine Months And Quarter Ended December 31 2022.
Due to some typographical error in the Financial Result we hereby file the Revised Unaudited Standalone Financial Results of the Company for Nine months & Quarter ended December 31 2022 in terms of the Regulations 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (Listing Regulations) The said Revised Unaudited Standalone Financial Results along with the Limited Review Report of the Statutory Auditors of the Company for the said period are enclosed herewith in terms of Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.The Meeting of Board of Directors of the Company commenced at 11:00 A.M. and concluded at 4:30 P.M.
Tue, 14 Feb 2023
Board Meeting Outcome for REVISED BOARD MEETING OUTCOME DATED 11.02.2023
In connection with Board Meeting Outcome dated 11-02-2023 there was a typographical error in the date of Appointment of Company Secretary. Hence the date has been rectified and all other agenda remains intact.In pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations 2015 we would like to inform you that Board Meeting of the Company was held i.e. on Saturday February 11th 2023 at 11:00 A.M. at the registered office of the Company the Board has considered and approved the following:1)The Un-audited Standalone Financial Results of the Company for the Nine months and Quarter ended December 31 2022 along with Limited Review Report thereon; 2)Resignation of Ms. Sonam Asati (Membership no: A67268) from the post of Company secretary w.e.f. 26th November 2022. 3)Appointment of Mr. Shubham Sharma (Membership no: A70122) as the Company secretary w.e.f. 11th February 2023. The Meeting of the Board of Directors commenced 11:00 A.M. and concluded at 4:30 P.M.

Technical Scans View Details >>

Wed, 29 Mar 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.30 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.45 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 6.01 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.19 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.25 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Panjon Ltd.

What is Panjon share price?
Can I buy Panjon shares now?
What is the Market Cap of Panjon?
What are the key metrics to analyse Panjon?
What is the 52 Week High and Low of Panjon?
What is the trend of Panjon share price?